The iMATTER Project: Improving Mood for Adolescents
This study, called The iMATTER Project, is looking at a program to help teenagers with depressive symptoms. It's testing a program called Brief Interpersonal Psychotherapy - Adolescent Skills Training (B-IPT-AST) against "services as usual" (SAU), which means any mental health services you might already receive. The goal is to see if B-IPT-AST is practical and helpful for preventing depression in primary care. You might be able to join if you are 13-17 years old, speak English, and have a specific score on a depression questionnaire (PHQ-9-M) during a doctor's visit. The researchers will look at how much participants like the program, how often they attend, and if they stay in the study to see if it's successful.
- Study design
- This is a pilot randomized controlled trial with 45 participants. You would be randomly assigned to either receive B-IPT-AST or "services as usual."
- What's involved
- If you participate, you would attend 6 sessions of B-IPT-AST (4 group and 2 individual sessions). You would also complete surveys at the beginning, during, and up to 6 weeks after the intervention.
- Compensation
- Not stated in the trial record.
- Follow-up
- You would be followed for up to 6 weeks after the intervention to assess acceptability and retention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
At a glance
Conditions
NCT07020572
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Children's Hospital of Philadelphia
Philadelphia, Pennsylvaniastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Molly F Davis, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Acceptability: A self-report measure, the Attitude Towards Intervention Questionnaire (ATI)0-6 Weeks Post-Intervention
A self-report measure, the Attitude Towards Intervention Questionnaire (ATI), will be completed by adolescents to assess acceptability of Brief Interpersonal Psychotherapy-Adolescent Skills Training (B-IPT-AST) following the intervention. The ATI includes 11 Likert scale items and one open-ended item for providing additional feedback. Likert scales vary by item but are generally 3- or 5-point scales (e.g., very helpful to very unhelpful). Each item is interpreted on its own (e.g., the percentage of teens who found B-IPT-AST very or a little helpful)
- AttendanceWeekly during B-IPT-AST
The number of individual and group B-IPT-AST sessions that teens attend will be tracked in order to report on the average number of group sessions attended (out of 4) for the total sample as well as the average number of individual sessions (out of 2) attended across the sample
- RetentionBaseline, 0-6 Weeks Post-Intervention
To gauge feasibility, retention will be assessed by comparing the number of families who remain in the study through post-intervention to the number who consented.
- Depression symptomsBaseline, 0-6 Weeks Post-Intervention
Change in depression symptoms will be measured by the Center for Epidemiologic Studies-Depression Scale (CES-D) which assesses the frequency of 20 depressive symptoms over the past week; CES-D scores range from 0 to 60 (scores of 16 or higher are considered elevated); higher scores indicate more depression symptoms
- Depression symptomsBaseline, 0-6 Weeks Post-Intervention
Change in depression symptoms will also be measured by the Patient Health Questionnaire 9-Item: Modified for Teens (PHQ-9-M). The PHQ-9-M assesses depression symptoms over the past 2 weeks and includes 13 items, 9 of which are included in the total score. Total scores range from 0-27, with higher scores indicating more depression symptoms
- Anxiety symptomsBaseline, 0-6 Weeks Post-Intervention
Change in anxiety symptoms will be assessed by the Screen for Child Anxiety Related Disorders (SCARED), a 41-item scale assessing symptoms corresponding to different anxiety disorders; the study team will examine total scores and the following subscales: panic, generalized anxiety disorder, and social anxiety; total scores range from 0-82 (25 or higher indicates clinical range); panic scores range from 0-26 (7 or higher indicates clinical range); generalized anxiety disorder scores range from 0-18 (scores of 9 or higher indicates clinical range); social anxiety scale ranges from 0-14 (scores 8 or higher indicate clinical range)